On January 5, 2023 Tvardi Therapeutics, Inc. ("Tvardi"), a privately held, clinical-stage biopharmaceutical company focused on the development of STAT3 inhibitors, reported that the management team will present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, in San Francisco, CA (Press release, Tvardi Therapeutics, JAN 5, 2023, View Source [SID1234625877]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation Details:
Date: Tuesday, January 10, 2023
Time: 5:30 p.m. PST
Location: The Westin St. Francis – Mission Bay (32nd Floor)